58 related articles for article (PubMed ID: 28551636)
1. Identification of MicroRNAs Involved in Resistance to Sunitinib in Renal Cell Carcinoma Cells.
Yamaguchi N; Osaki M; Onuma K; Yumioka T; Iwamoto H; Sejima T; Kugoh H; Takenaka A; Okada F
Anticancer Res; 2017 Jun; 37(6):2985-2992. PubMed ID: 28551636
[TBL] [Abstract][Full Text] [Related]
2. Molecular and functional characterization of reversible-sunitinib-tolerance state in human renal cell carcinoma.
Zaccagnino A; Vynnytska-Myronovska B; Stöckle M; Junker K
J Cell Mol Med; 2024 May; 28(9):e18329. PubMed ID: 38693863
[TBL] [Abstract][Full Text] [Related]
3. Expressions of miR-96-5p, miR-29b-3p, and Their Target Gene THBS1 in Clear Cell Renal Cell Carcinoma and Sunitinib Resistance.
Wu S; Wang Y
Altern Ther Health Med; 2023 Nov; ():. PubMed ID: 37971460
[TBL] [Abstract][Full Text] [Related]
4. Molecular and Functional Analysis of Sunitinib-Resistance Induction in Human Renal Cell Carcinoma Cells.
Rausch M; Rutz A; Allard PM; Delucinge-Vivier C; Docquier M; Dormond O; Wolfender JL; Nowak-Sliwinska P
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208775
[TBL] [Abstract][Full Text] [Related]
5. Monitoring the Vascular Response and Resistance to Sunitinib in Renal Cell Carcinoma
Robinson SP; Boult JKR; Vasudev NS; Reynolds AR
Cancer Res; 2017 Aug; 77(15):4127-4134. PubMed ID: 28566330
[TBL] [Abstract][Full Text] [Related]
6. Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib-Treated Cancer.
Diekstra MH; Fritsch A; Kanefendt F; Swen JJ; Moes D; Sörgel F; Kinzig M; Stelzer C; Schindele D; Gauler T; Hauser S; Houtsma D; Roessler M; Moritz B; Mross K; Bergmann L; Oosterwijk E; Kiemeney LA; Guchelaar HJ; Jaehde U
CPT Pharmacometrics Syst Pharmacol; 2017 Sep; 6(9):604-613. PubMed ID: 28571114
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer.
Iacovelli R; Cossu Rocca M; Galli L; De Giorgi U; Sabbatini R; Santoni M; Mosca A; Fornarini G; Massari F; Masini C; Bersanelli M; Biasco E; Lolli C; Guida A; Berardi R; Terrone C; Pastorino A; Ardizzoni A; Pinto C; Buti S; Nolè F; Tortora G
Urol Oncol; 2017 Sep; 35(9):541.e7-541.e13. PubMed ID: 28572027
[TBL] [Abstract][Full Text] [Related]
8. miR-431-5p alters the epithelial-to-mesenchymal transition markers by targeting
Kong Q; Han J; Deng H; Wu F; Guo S; Ye Z
Onco Targets Ther; 2018; 11():6489-6503. PubMed ID: 30323624
[TBL] [Abstract][Full Text] [Related]
9. Combination of Anti-Angiogenics and Immunotherapies in Renal Cell Carcinoma Show Their Limits: Targeting Fibrosis to Break through the Glass Ceiling?
Teisseire M; Giuliano S; Pagès G
Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38397987
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of tyrosine kinase inhibitor resistance in renal cell carcinoma.
Sweeney PL; Suri Y; Basu A; Koshkin VS; Desai A
Cancer Drug Resist; 2023; 6(4):858-873. PubMed ID: 38239394
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel microRNA mimic repressors of ribosome biogenesis.
Bryant CJ; McCool MA; Rosado González GT; Abriola L; Surovtseva YV; Baserga SJ
Nucleic Acids Res; 2024 Feb; 52(4):1988-2011. PubMed ID: 38197221
[TBL] [Abstract][Full Text] [Related]
12. Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma.
Astore S; Baciarello G; Cerbone L; Calabrò F
Cancer Drug Resist; 2023; 6(3):517-546. PubMed ID: 37842234
[TBL] [Abstract][Full Text] [Related]
13. Potential therapeutic target secretogranin II might cooperate with hypoxia-inducible factor 1α in sunitinib-resistant renal cell carcinoma.
Fukumoto W; Yoshino H; Horike SI; Kawakami I; Tamai M; Arima J; Kawahara I; Mitsuke A; Sakaguchi T; Inoguchi S; Meguro-Horike M; Tatarano S; Enokida H
Cancer Sci; 2023 Oct; 114(10):3946-3956. PubMed ID: 37545017
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA Expression Signatures in Clear Cell Renal Cell Carcinoma: High-Throughput Searching for Key miRNA Markers in Patients from the Volga-Ural Region of Eurasian Continent.
Gilyazova I; Ivanova E; Izmailov A; Sharifgaliev I; Karunas A; Pudova E; Kobelyatskaya A; Gilyazova G; Izmailova A; Pavlov V; Khusnutdinova E
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108073
[TBL] [Abstract][Full Text] [Related]
15. A Four-MicroRNA Panel in Serum as a Potential Biomarker for Screening Renal Cell Carcinoma.
Li R; Lu C; Li X; Chen X; Huang G; Wen Z; Li H; Tao L; Hu Y; Zhao Z; Chen Z; Lai Y
Front Genet; 2022; 13():897827. PubMed ID: 35938021
[No Abstract] [Full Text] [Related]
16. Advances in Renal Cell Carcinoma Drug Resistance Models.
Xiang Y; Zheng G; Zhong J; Sheng J; Qin H
Front Oncol; 2022; 12():870396. PubMed ID: 35619895
[TBL] [Abstract][Full Text] [Related]
17. Discovery of VEGFR2 inhibitors by integrating naïve Bayesian classification, molecular docking and drug screening approaches.
Kang D; Pang X; Lian W; Xu L; Wang J; Jia H; Zhang B; Liu AL; Du GH
RSC Adv; 2018 Jan; 8(10):5286-5297. PubMed ID: 35542432
[TBL] [Abstract][Full Text] [Related]
18. Circle-Seq reveals genomic and disease-specific hallmarks in urinary cell-free extrachromosomal circular DNAs.
Lv W; Pan X; Han P; Wang Z; Feng W; Xing X; Wang Q; Qu K; Zeng Y; Zhang C; Xu Z; Li Y; Zheng T; Lin L; Liu C; Liu X; Li H; Henriksen RA; Bolund L; Lin L; Jin X; Yang H; Zhang X; Yin T; Regenberg B; He F; Luo Y
Clin Transl Med; 2022 Apr; 12(4):e817. PubMed ID: 35474296
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-642b-3p functions as an oncomiR in gastric cancer by down-regulating the CUB and sushi multiple domains protein 1/smad axis.
Liu H; Chen Y; Zhou L; Jiang X; Zhou X
Bioengineered; 2022 Apr; 13(4):9613-9627. PubMed ID: 35412956
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanisms of Resistance to Immunotherapy and Antiangiogenic Treatments in Clear Cell Renal Cell Carcinoma.
Ballesteros PÁ; Chamorro J; Román-Gil MS; Pozas J; Gómez Dos Santos V; Granados ÁR; Grande E; Alonso-Gordoa T; Molina-Cerrillo J
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
